No Data
No Data
Express News | Truist Securities Reiterates Buy on Arvinas, Maintains $65 Price Target
Arvinas Gets New Chief Medical Head
Arvinas Appoints New Chief Medical Officer for Clinical Programs
Press Release: Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer - Awards Dr. Berkowitz an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) - NEW HAVEN, Conn., March 18, 2024
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
- Awards Dr. Berkowitz an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) -NEW HAVEN, Conn., March 18, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biot
Big Pharma Patent Cliffs Seen Fueling Oncology M&A This Year
No Data